Targeted Next Generation Sequencing for the Efficacy of Trastuzumab Neoadjuvant Chemotherapy in Breast Cancer
Clinical trial NCT03728829 · UNKNOWN
Trial details
- NCT number
- NCT03728829
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-07-01
- Primary completion
- 2022-10-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.